Clinical Trial Update: A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED) [Phase 1]

View source ↗

Summary

This Phase 1, single-dose crossover study of MK0893 in patients with Type 2 Diabetes Mellitus has completed and results were posted in 2012. The sponsor is Merc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK0893

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2012-05-08